Integrated Wealth Concepts’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Integrated Wealth Concepts's KNSA Position: Q3 2026 in Review
Integrated Wealth Concepts opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 12,824 shares worth $957K. The stake represents 0.01% of the portfolio and ranks #1291 among its holdings.
305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Integrated Wealth Concepts held 12,824 shares of Kiniksa Pharmaceuticals worth $957K as of Q3 2026.
- Kiniksa Pharmaceuticals was a new Integrated Wealth Concepts position in Q3 2026.
- Kiniksa Pharmaceuticals made up 0.01% of Integrated Wealth Concepts's portfolio in Q3 2026, its #1291 holding.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Integrated Wealth Concepts's 13F filing for Q3 2026, filed 17 Nov 2026.